Literature DB >> 22427101

CD147 silencing via RNA interference reduces tumor cell invasion, metastasis and increases chemosensitivity in pancreatic cancer cells.

Yuqin Pan1, Bangshun He, Guoqi Song, Qian Bao, Zhipeng Tang, Fuliang Tian, Shukui Wang.   

Abstract

CD147, which belongs to the immunoglobulin superfamily, is a multifunctional glycoprotein that has been shown to increase tumor invasion, metastasis and multidrug resistance. To define the role of CD147 in invasion and metastasis more precisely, we utilized gene silencing to inhibit the expression of CD147 in pancreatic cancer cells. We observed that CD147 expression was significantly impeded at both the mRNA and protein levels and resulted in a decrease of MMP-2 and MMP-9 activities. There was also a decrease of MCT1 expression in the invasion and metastasis potential of pancreatic cancer cells, as well as increased chemosensitivity to gemcitabine in Panc-1 cells. Overall, these results suggest that CD147 plays an important role in the invasion, metastasis and chemosensitivity of the human pancreatic cancer cell line Panc-1, indicating that CD147 may be a promising therapeutic target for pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22427101     DOI: 10.3892/or.2012.1729

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  22 in total

1.  HAb18G/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s.

Authors:  Ling Li; Wenhua Tang; Xiaoqing Wu; David Karnak; Xiaojie Meng; Rachel Thompson; Xinbao Hao; Yongmin Li; Xiaotan T Qiao; Jiayuh Lin; James Fuchs; Diane M Simeone; Zhi-Nan Chen; Theodore S Lawrence; Liang Xu
Journal:  Clin Cancer Res       Date:  2013-10-16       Impact factor: 12.531

2.  Relationship between CD147 and expression of amino acid transporters (LAT1 and ASCT2) in patients with pancreatic cancer.

Authors:  Kyoichi Kaira; Kazuhisa Arakawa; Kimihiro Shimizu; Noboru Oriuchi; Shushi Nagamori; Yoshikatsu Kanai; Tetsunari Oyama; Izumi Takeyoshi
Journal:  Am J Transl Res       Date:  2015-02-15       Impact factor: 4.060

Review 3.  Eviction from the sanctuary: Development of targeted therapy against cell adhesion molecules in acute lymphoblastic leukemia.

Authors:  Sonali P Barwe; Anthony Quagliano; Anilkumar Gopalakrishnapillai
Journal:  Semin Oncol       Date:  2017-07-11       Impact factor: 4.929

4.  Cell surface lactate receptor GPR81 is crucial for cancer cell survival.

Authors:  Christina L Roland; Thiruvengadam Arumugam; Defeng Deng; Shi He Liu; Bincy Philip; Sobeyda Gomez; William R Burns; Vijaya Ramachandran; Huamin Wang; Zobeida Cruz-Monserrate; Craig D Logsdon
Journal:  Cancer Res       Date:  2014-06-13       Impact factor: 12.701

Review 5.  Metabolic changes associated with tumor metastasis, part 1: tumor pH, glycolysis and the pentose phosphate pathway.

Authors:  Valéry L Payen; Paolo E Porporato; Bjorn Baselet; Pierre Sonveaux
Journal:  Cell Mol Life Sci       Date:  2015-12-01       Impact factor: 9.261

6.  c-Jun-mediated β-1,3-N-acetylglucosaminyltransferase 8 expression: A novel mechanism regulating the invasion and metastasis of colorectal carcinoma cells.

Authors:  Chunliang Liu; Hao Qiu; Meiyun Yu; Zerong Wang; Yaqin Yuan; Zhi Jiang; Xuejun Shao; Dong Hua; Min Liu; Shiliang Wu
Journal:  Oncol Lett       Date:  2017-07-20       Impact factor: 2.967

7.  CD147 promotes the proliferation, invasiveness, migration and angiogenesis of human lung carcinoma cells.

Authors:  Shaoxing Yang; Fei Qi; Chuanhao Tang; Hong Wang; Haifeng Qin; Xiaoyan Li; Jianjie Li; Weixia Wang; Changyun Zhao; Hongjun Gao
Journal:  Oncol Lett       Date:  2016-12-14       Impact factor: 2.967

8.  EMMPRIN/CD147 expression is associated with disease-free survival of patients with colorectal cancer.

Authors:  Shaojun Zhu; Dake Chu; Yang Zhang; Xuxia Wang; Li Gong; Xiujuan Han; Li Yao; Miao Lan; Yanhong Li; Wei Zhang
Journal:  Med Oncol       Date:  2013-02-07       Impact factor: 3.064

9.  Identification of an HLA-A2-restricted CD147 epitope that can induce specific CTL cytotoxicity against drug resistant MCF-7/Adr cells.

Authors:  Chuang Qu; Shuhui Gao; Hongwei Shao; Wenfeng Zhang; Huabben Bo; Xin Lu; Tianjiao Chen; Jing Kou; Yue Wang; Gui Si Chen; Shulin Huang; Han Shen
Journal:  Oncol Lett       Date:  2018-02-16       Impact factor: 2.967

10.  EMMPRIN is an independent negative prognostic factor for patients with astrocytic glioma.

Authors:  Li Tian; Yang Zhang; Yu Chen; Min Cai; Hailong Dong; Lize Xiong
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.